Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.
about
Putative biomarkers and targets of estrogen receptor negative human breast cancerCucurbitacins - An insight into medicinal leads from natureInhibition of Integrin-HER2 signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppressionCucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.Teucrium plant species as natural sources of novel anticancer compounds: antiproliferative, proapoptotic and antioxidant properties.Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest.An updated review of Cucurbitacins and their biological and pharmacological activities.The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancerAn Oxidoreductase AioE is Responsible for Bacterial Arsenite Oxidation and Resistance.Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.Treatment with cucurbitacin B alone and in combination with gefitinib induces cell cycle inhibition and apoptosis via EGFR and JAK/STAT pathway in human colorectal cancer cell lines.Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro.Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells.Cucurbitacin B and SCH772984 exhibit synergistic anti-pancreatic cancer activities by suppressing EGFR, PI3K/Akt/mTOR, STAT3 and ERK signaling.Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
P2860
Q27003285-BA90BAC7-0DB4-41CB-8AC1-9CD94243D32DQ28082425-160E503A-CB8C-4B07-B35B-0362959930D5Q33688434-62DAB525-42F3-4CD0-84F2-0725C84EC466Q34444520-9761B404-FAB5-4106-9E50-AE09F7BC5AA9Q34581026-CB2A136C-3753-47C3-90CA-AF8487C1A472Q35162090-FCA9769F-9A55-4A5B-85B3-C8B0138085C3Q35631729-E346029D-801C-4632-BDE1-9238691946BCQ36011864-928CAF00-6CB2-47E3-B2CD-416F38E3D5CCQ36347643-7A0EB1EF-8DE7-421E-825A-F7A878574FE3Q36763291-7BD481A7-B771-4B3B-B66F-A261EF96307DQ37609697-513354E0-DEF5-495E-90DB-9BA265EF65DDQ38616768-110A671F-9C03-4118-BAFF-C9BC52F92389Q38852066-656C9F55-EF2D-45E8-83AA-EA584214500DQ38866753-1E27E0EF-8194-4699-AA32-52E32963F3A8Q46723109-41DD96F4-02F0-4916-8175-A94954A58DCDQ47141971-EC59AAB7-4D5D-433D-B270-5864BEA11CB0Q47265475-57C4B120-3903-489D-9B64-0639FF552B9E
P2860
Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antiproliferative effects of c ...... obstruction of the cell cycle.
@ast
Antiproliferative effects of c ...... obstruction of the cell cycle.
@en
type
label
Antiproliferative effects of c ...... obstruction of the cell cycle.
@ast
Antiproliferative effects of c ...... obstruction of the cell cycle.
@en
prefLabel
Antiproliferative effects of c ...... obstruction of the cell cycle.
@ast
Antiproliferative effects of c ...... obstruction of the cell cycle.
@en
P2093
P2860
P356
P1476
Antiproliferative effects of c ...... obstruction of the cell cycle.
@en
P2093
Apichart Suksamrarn
Duncan R Smith
Pimpicha Patmasiriwat
Sumana Dakeng
Suwit Duangmano
Weena Jiratchariyakul
P2860
P304
P356
10.3390/IJMS11125323
P407
P577
2010-12-22T00:00:00Z